AVBP

ArriVent BioPharma, Inc. Common StockNASDAQHealthcare

$24.89+2.77%ClosedMarket Cap: $1.10B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-23	B. Riley Securities	—	Buy	—
2026-03-06	Citigroup	—	Buy	—
2026-03-06	Oppenheimer	—	Outperform	—
2026-03-06	HC Wainwright & Co.	—	Buy	—
2025-11-11	Citigroup	—	Buy	—
2025-08-12	Citigroup	—	Buy	—
2025-08-12	HC Wainwright & Co.	—	Buy	—
2025-06-24	Guggenheim	—	Buy	—
2025-06-24	Oppenheimer	—	Outperform	—
2025-05-14	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.25	$35.9M	6
Sun Dec 31	$-1.47	$131.0M	7
Mon Dec 31	$0.84	$266.8M	2
Tue Dec 31	$3.55	$433.9M	5